Docebo (DCBO)
(Delayed Data from NSDQ)
$29.99 USD
-0.31 (-1.02%)
Updated Aug 1, 2025 04:00 PM ET
After-Market: $30.06 +0.07 (0.23%) 7:58 PM ET
3-Hold of 5 3
D Value A Growth D Momentum C VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
DCBO 29.99 -0.31(-1.02%)
Will DCBO be a Portfolio Killer in August?
Zacks Investment Research is releasing its prediction for DCBO based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for DCBO
Docebo Inc. (DCBO) Tops Q1 Earnings and Revenue Estimates
Olo Inc. (OLO) Q1 Earnings and Revenues Top Estimates
DCBO: What are Zacks experts saying now?
Zacks Private Portfolio Services
Backblaze, Inc. (BLZE) Reports Q1 Loss, Tops Revenue Estimates
Docebo Inc. (DCBO) Lags Q4 Earnings Estimates
Definitive Healthcare (DH) Surges 8.4%: Is This an Indication of Further Gains?
Other News for DCBO
Docebo Announces Participation in Upcoming Investor Conferences in August & September | ...
Docebo to Host Second Quarter Fiscal 2025 Conference Call | DCBO Stock News
Docebo Inc (DCBO) Shares Down 2.96% on Jun 13
Docebo Inc. Announces Shareholder Meeting Results and Auditor Appointment
Docebo Announces Shareholder Meeting Results and Auditor Appointment